Results 191 to 200 of about 461,819 (327)
Abstract In Japan, the percentage of approved drugs with pediatric indications increased to 30% in 2010‐2015, but no further increase was observed through 2020. The Ministry of Health, Labor, and Welfare in Japan presented draft future directions to promote pediatric drug development, where the modeling and simulation (M&S) approach was introduced as a
Akinori Nakashima+5 more
wiley +1 more source
Bowel wall thickness, as measured by bowel ultrasound, demonstrates high diagnostic accuracy in evaluating patients with suspected inflammatory bowel disease (IBD). When combined with other bowel ultrasound parameters, this non‐invasive tool can serve as an effective screening method to accelerate IBD diagnosis.
Amanda Hendricks, Henra Muller
wiley +1 more source
Plasma interleukin-22 concentration and disease activity in inflammatory bowel disease. [PDF]
Cabrera C+10 more
europepmc +1 more source
A Comprehensive Review of Food-Derived Compounds Targeting Pyroptosis for Colitis Therapy: From Effects to Mechanisms. [PDF]
Zhao JW, Li LY, Ye FW, Zhao WY.
europepmc +1 more source
Point‐Counterpoint: Adult patients in children's hospitals
Abstract Adults continue to be admitted to children's hospitals for a variety of reasons. But should they? Transfer from the pediatric to adult hospital setting is the standard of high‐quality care for any young adult. Adult hospitalists are equipped to care for these patients.
Meg Groom+3 more
wiley +1 more source
Mechanisms of NLRP3 inflammasome in pathogenesis and progression of inflammation-related gastrointestinal diseases. [PDF]
Liu F, Shao B, Zhu Y, Xue X, Wu X.
europepmc +1 more source
Abstract Objectives Pediatric inflammatory bowel disease (PIBD) incidence has increased in recent decades but may be stabilizing, prompting exploration of incidence changes, disease distribution, and severity. Methods From 2017 to 2019, patients under 18 years with PIBD symptoms were recruited from nine hospitals in South‐Eastern Norway for ...
Svend Andersen+12 more
wiley +1 more source
The association between 4-HPR-mediated LCN2 suppression and reduced intestinal cell senescence in ulcerative colitis. [PDF]
Pan X+6 more
europepmc +1 more source
Abstract Inflammatory bowel diseases (IBD) require effective therapies to prevent morbidity and maintain quality of life. The introduction of biologic agents, beginning with monoclonal antibodies targeting tumor necrosis factor (TNF) alpha, has launched a new era of advancements that have markedly improved short‐ and long‐term outcomes of Crohn's ...
Lina M. Felipez+7 more
wiley +1 more source
Potential miRNAs as Diagnostic Biomarkers for Differentiating Disease States in Ulcerative Colitis: A Systematic Review. [PDF]
Khan AU, Chacon-Millan P, Stiuso P.
europepmc +1 more source